MondayNov 25, 2013 9:38 am

On the Move Systems Corp. (OMVS) Reports Progress in Sports Getaway Deal

Today before the opening bell, On the Move Systems Corp. reported substantial progress in its aggressive bid to offer sports getaway travel packages nationwide to fans. The company’s executive leadership met with the company with which it is discussing partnership prospects, The XPerience, in Daytona just last week. Current the two companies are discussing the possibility of making fantasy travel packages for racing fans and sponsors available through On the Move Systems’ online travel bookings portal. If successful, the agreement would enable On the Move Systems to offer comprehensive booking deals on transportation, lodging, and more to customers traveling to…

Continue Reading

MondayNov 25, 2013 9:13 am

OBJ Enterprises, Inc. (OBJE) Signs LOI with Corv Studios

Today before the opening bell, OBJ Enterprises, a rapidly growing mobile game developer, announced it has signed a letter of intent with development firm Corv Studios for licensing and developing game titles created by the firm. Working through its subsidiary, Obscene Interactive, OBJ Enterprises seeks to partner with Corv for creating and publishing engaging, creative mobile gaming titles for smartphones and tablets. If the agreement is successful, both parties will publish the new games under OBJ Enteprises’ Novalon Games brand. Expansion of Novalon Games' portfolio of titles will be a major focus for us in 2014," said OBJ Enterprises CEO…

Continue Reading

FridayNov 22, 2013 5:56 pm

GeoVax Labs, Inc. (GOVX) Recruits Dr. Arban Domi as Director of Vector Development

GeoVax Labs, an innovative biotechnology company currently developing vaccines in order to prevent and treat HIV/AIDS, announced earlier today the appointment of Arban Domi, Ph.D., as its Director, Vector Development. Dr. Domi will not only be an influential player in the continued development of GeoVax's HIV vaccines, of which are now being evaluated in human clinical trials, but also in the development of versions of the company's vaccines for the subtypes of HIV affecting the developing world. In addition, Dr. Domi's expertise will be instrumental in the company's evaluation of the suitability of vaccine constructs for commercial-scale vaccine manufacturing processes.…

Continue Reading

FridayNov 22, 2013 5:25 pm

New Colombia Resources, Inc. (NEWC) to Advance La Tabaquera Coal Project by Selling Raw Building Materials into Hungry Columbian Market

New Colombia Resources, which is primarily focused on developing high-quality metallurgical coal properties in the Republic of Colombia, announced a brilliant strategic move today as the company will be rapidly moving to offset the closure of all the rock quarries in Bogota by environmental authorities via their own plans to begin extracting raw building materials from the company's 100%-owned flagship La Tabaquera coal project in Guaduas (estimated 17M tonnes of reserves), starting as early as this January. This is a marriage of pure logistical upside and mounting demand, as the requirements generated by the Columbian government's sweeping Fourth Generation Highways…

Continue Reading

FridayNov 22, 2013 12:50 pm

International Stem Cell Corp. (ISCO) Receives Favorable Review in Seeking Alpha Article

International Stem Cell was recently the topic of a Seeking Alpha article by contributing writer Kingmaker, who outlines the company’s stem cell technology, third-quarter financial results, its upcoming investigational new drug (IND) filing, and its subsequent market potential. To read the full article visit: http://seekingalpha.com/article/1857401 International Stem Cell is a biotech company developing new stem cell technology based on a natural process called parthenogenesis, in which stem cells are derived from unfertilized human eggs. As the author notes, International Stem Cell’s parthenogenesis stem cells “demonstrate superiority” in meeting key criteria in order to be effectual in therapeutic application. With its…

Continue Reading

FridayNov 22, 2013 11:37 am

Pan Global Corp. (PGLO) Advances Hydro Project Acquisition, Financial Due Diligence Meets Requirements

Green energy advocate Pan Global has received the final financial due diligence report produced by Ernst & Young, LLP India (E&Y India), enabling the company to move forward with the previously announced staggered acquisition of a 5.7 MW small-hydro project in northern India. Pan Global reports that the financial report meets the financial due diligence requirements of the acquisition agreement with Regency Yamuna Energy Ltd. (RYEL), a privately held Indian corporation. "We thank E&Y India for their professionalism and timely delivery of their financial due diligence report on the project. We retained E&Y India to perform this important task because…

Continue Reading

FridayNov 22, 2013 11:34 am

Progress in the Development of VistaGen’s (VSTA) AV-101 Prodrug Candidate for Treating Neuropathic Pain and Depression

With grant funding from the U.S. National Institutes of Health (NIH), biotechnology company VistaGen Therapeutics, Inc. has successfully completed Phase 1 development of AV-101, an orally available small molecule prodrug candidate. AV-101 is targeted at the multibillion-dollar neurological disease and disorder market, including depression and neuropathic pain, which is a serious and chronic condition that causes pain after an injury or disease of the peripheral or central nervous system. In support of the company’s nonclinical and Phase 1 clinical development of AV-101, the NIH awarded VistaGen more than $8.8 million in grant funding. Also known as “L-4-chlorokynurenine” and “4-CI-KYN,” AV-101…

Continue Reading

FridayNov 22, 2013 10:04 am

Max Sound Corp. (MAXD) to Take Stage at 6th Annual LD MICRO Conference

Max Sound, an HD audio technology company with proprietary software that significantly improves sound quality without increasing file size, today announced that CEO John Blaisure will be presenting at the Sixth Annual LD MICRO Conference on Tuesday, December 3rd, at 10:30am PST, at the Luxe Hotel Sunset Boulevard in Los Angeles. According today’s press release, Blaisure will review Max Sound’s business outlook subsequent to the recent introduction of MAX-D's HD audio technology on the Qualcomm Hexagon DSP processor. The presentation will be webcast live and may be accessed on the company's website, http://maxsound.com/invest. The presentation will be archived for 90…

Continue Reading

FridayNov 22, 2013 9:36 am

Experienced, Savvy Board of Directors at Helm of Kallo, Inc. (KALO)

In 2010, global expenditures for healthcare reached $6.3 trillion. Many factors, including increasing numbers of people with chronic diseases, a growing global elderly population and the increased need for medical attention that comes with it, and the ballooning of health conditions arising from unhealthy lifestyle choices, contributed to that jump. Global demand for healthcare is projected to increase as these influences become more pronounced, and as costs rise to cover the growing healthcare organizational expenditures arising from meeting that demand. Kallo, a healthcare information technology company, has developed a suite of technologies and products to help healthcare organizations contain and…

Continue Reading

FridayNov 22, 2013 9:32 am

Neutra Corp. (NTRR) Targeting Innovative Nutraceuticals Industry for Development of New Health Supplement

Healthy lifestyle company Neutra Corp., along with its joint-venture partner Surface to Air Solutions, LLC (S2O2), are collaborating to bring to market a revolutionary new health supplement for the rapidly growing nutraceuticals industry. The joint venture is currently in talks to acquire or partner with a company working on the development of a supplement designed to improve lung function, memory, focus, problem solving and awareness. The supplement is all-natural, and packed with smart nutrients, antioxidants and botanicals engineered to enhance cognition. “The potential market for this product is massive,” NTRR CEO Sydney Jim stated in the news release. “The nutraceuticals…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered